AzTrials
AzTrials

FibromyalgiaNCT04265196

Group Therapy for Fibromyalgia:the Effectiveness of Mindfulness -Based VS Cognitive-behavioral Therapy

A study testing cognitive behavioral group therapy and Mindfulness-based group therapy in people with Fibromyalgia and PTSD, run by Bar-Ilan University, Israel at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was conducted as part of a collaboration between the Maccabi Health Fund and Bar Ilan University. Fibromyalgia is a chronic pain disorder, highly co-morbid with depression, stress, and anxiety. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Fibromyalgia, PTSD, Depression
What is being tested?
cognitive behavioral group therapy and Mindfulness-based group therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteIsrael
Study dates
4 Apr 2019to 31 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients diagnosed with fibromyalgia
  • Hebrew speakers

Who cannot join

  • Patients who are actively suicidal
  • Patients who suffering from psychotic status
  • Patients who are chronically use addictive substances,
  • Patients who had unusual cognitive or physical disability that would prevent them from participating in mindfulness exercises

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Bar Ilan University

    Ramat Gan

Other trials in Israel

About this study

Official title: Group Therapy for Fibromyalgia: RCT Testing the Effectiveness of Mindfulness -Based Therapy Versus Cognitive-behavioral Therapy

This study was conducted as part of a collaboration between the Maccabi Health Fund and Bar Ilan University. Fibromyalgia is a chronic pain disorder, highly co-morbid with depression, stress, and anxiety. the investigators aim to examine the effect of group cognitive-behavioral therapy (CBT) and mindfulness-based intervention (MBI) among fibromyalgia patients. the investigators will also examine which intervention fits which patient, according to one's individual characteristics, in hope that this would enable Maccabi to offer personalized treatment. Furthermore, the investigators wish to identify the underlying cognitive and psychopathological mechanisms (measured during treatment) by which each intervention works.

Read the detailed description

Fibromyalgia is a chronic pain disorder, highly co-morbid with depression, stress, and anxiety. the investigators aim to examine the effect of group cognitive-behavioral therapy (CBT) and mindfulness-based intervention (MBI) among fibromyalgia patients. the investigators will also examine which intervention fits which patient, according to one's individual characteristics, in hope that this would enable Maccabi to offer personalized treatment. Furthermore, the investigators wish to identify the underlying cognitive and psychopathological mechanisms (measured during treatment) by which each intervention works.

First, the investigators expect that CBT and MBI will lead to greater improvement in physical, psychological, and behavioral measures among fibromyalgia patients compared to waitlist controls. Second, the investigators expect that MBI and CBT will have a differential effect, so that some outcome variables will show greater improvement following one intervention, but not the other. Furthermore, factors such as age, illness duration, symptom severity, and initial psychopathology levels will affect one's level of improvement following these interventions. Finally, the investigators expect to identify differential mechanisms driving each intervention. The study is a randomized controlled trial (RCT), including 90 fibromyalgia patients, randomly assigned to 3 conditions: (1) Group CBT (n=30), (2) MBI (n=30), (3) Waitlist control group, subsequently assigned to treatment (n=30). Participants will complete selfreport questionnaires tapping psychological (depression, stress), cognitive (observing negative experiences "from afar", cognitive flexibility towards pain) and physical (pain, body awareness) aspects, at 4 assessments: pre-/during/post- treatment, and 3 months after treatment.

To date, no RCT comparing CBT and MBI for fibromyalgia was conducted. Comparing them would be highly important, as they are the two most notable psychological interventions for chronic pain conditions. This study would enable Maccabi to offer improved psychological services for fibromyalgia. Furthermore, group therapy may serve as an effective treatment meeting both Maccabi's needs (a short, economic intervention) and patients' needs (a condition-specific treatment, offering group support and stigma reduction).

Being tested
cognitive behavioral group therapy, Mindfulness-based group therapy
Medical subject headings
Fibromyalgia, Stress Disorders, Post-Traumatic, Depression, Parasomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cognitive behavioral group therapyOther

    A unique protocol that includes cognitive-behavioral psychological therapy with emphasis on coping with pain

  • Mindfulness-based group therapyOther

    Unique protocol that includes mindfulness-based psychological therapy with emphasis on coping with pain

Study groups in NCT04265196
Study groupRoleWhat they receive
cognitive behavioral group therapyExperimentalA Cognitive Behavioral Therapy intervention is based on a unique protocol built in the light of previous research in the field and includes a 10-week treatment focused on coping with pain and stress.
Receives: Other: cognitive behavioral group therapy
Mindfulness-based group therapyExperimentalA mindfulness-based group therapy intervention was built inspired by a mindfulness protocol that is effective in treating pain, and includes adjustments to the physical distress of fibromyalgia patients as well as an emphasis on coping with stress and pain.
Receives: Other: Mindfulness-based group therapy
control groupNo interventionA control group will wait for 3 months, during which the subjects will complete the questionnaires and only after the end of the period will they participate in the treatment so that it will serve as a control group without intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Fibromyalgia Impact Questionnaire Revised (FIQR)

    Self-report questionnaire, which includes 21 items and assesses symptoms and functioning of fibromyalgia patients, taking into account the frequency of symptoms, their intensity, and the degree of impairment of patient function

    Measured: change through study completion, an average of 6 month

  2. Perceived Stress Scale (PSS)

    A 10-item questionnaire measuring the level at which events occurred in the individual's life in the past month is perceived as unpredictable, uncontrollable and overwhelming. A higher score indicates a higher level of perceived stress.

    Measured: change through study completion, an average of 6 month

  3. The Patient Health Questionnaire-9 (PHQ-9)

    A self-reported 9-item questionnaire to measure symptoms of major depression. The items relate to the key aspects of DSM, including thoughts of death, loss of appetite, sadness and mental pain, and negative cognitions.

    Measured: change through study completion, an average of 6 month

  4. Pain (VAS)

    Self-report questionnaire designed to measure pain intensity and unpleasantness caused by pain. This questionnaire is widely used in pain clinics. It includes one item that can be graded on a continuous scale that ranges from 0 (no pain) to 10 (the worst pain that can be).

    Measured: change through study completion, an average of 6 month

  5. Sleep Quality (Pittsburgh Sleep Quality Index)

    A questionnaire developed to measure sleep quality and sleep disorder. The questionnaire includes 19 items measuring seven components of sleep (sleep quality, sleep onset, sleep duration, sleep efficiency, sleep disturbance, sleep medication use, and daily functioning impairment) over the past four weeks.

    Measured: change through study completion, an average of 6 month

Secondary outcomes (10)
  1. Mindfulness (Five Fact Mindfulness Questionnaire)

    The questionnaire includes 5 scales, which relate to various mindfulness factors - observing / paying attention to internal and external stimuli , the ability to verbally describe or label stimuli, behavior, non-judgmental and non-reactivity

    Measured: change through study completion, an average of 6 month

  2. Psychological Inflexibility in Pain (PIPS)

    A questionnaire designed to assess the extent to which a person is trying to control and struggle with physical pain, as opposed to trying and accepting it, and "making friends" with him. The questionnaire includes 12 items.

    Measured: change through study completion, an average of 6 month

  3. Body Vigilance (BVS)

    Self-report questionnaire designed to examine attention regarding normal physical processes, periodic susceptibility / rhythm sensitivity, and ability to predict physical responses. Each item in the questionnaire is rated on a 7-rank Likert scale (1 = not at all true, 7 = very true), with a higher score representing a higher body awareness.

    Measured: change through study completion, an average of 6 month

  4. Meta-cognition (MCQ-30)

    A self-report questionnaire designed to test metacognitive ability, with an emphasis on beliefs, judgment, and regulation.

    Measured: change through study completion, an average of 6 month

  5. Difficulties in emotion regulation (DERS)

    Self-report questionnaire designed to test difficulties in the emotional regulation process. The questionnaire contains 36 items that relate to awareness of emotions and emotional reactions

    Measured: change through study completion, an average of 6 month

  6. Pain Catastrophizing (PCS)

    A questionnaire examining the tendency to intensify the threat and sense of helplessness arising from pain, and the inability to prevent it

    Measured: change through study completion, an average of 6 month

  7. Trauma Exposure (The Life Events Checklist)

    An index that examines exposure to traumatic life events. Exposure is rated at various levels (direct, indirect, experience)

    Measured: Pre-treatment

  8. Self- Compassion (SCS)

    Self-report questionnaire that examines the participant's compassionate ability. The questionnaire refers to 3 components of compassion - Self-Kindness, Common Humanity and Mindfulness

    Measured: change through study completion, an average of 6 month

  9. Distress tolerance

    Self-report questionnaire covering four different categories: perceived ability to bear emotional distress, subjective assessment of distress, attentiveness to negative emotions, and regulation efforts to reduce distress.

    A combination of categories allows for an overall measure of distress resistance

    Measured: change through study completion, an average of 6 month

  10. Alexithymia

    Self-Reporting Questionnaire Examining three subscales: (1) difficulty identifying feelings and distinguishing between feelings and bodily sensations in emotional activation, (2) difficulty in the verbal expression of emotions, and (3) externally oriented thinking.

    Measured: change through study completion, an average of 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2020
  2. Study start4 Apr 2019
  3. Primary completion1 Oct 2021
  4. Study completion31 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04265196
Sponsor's protocol ID
10112019
Status last verified
Oct 2022
First submitted
2 Feb 2020
Last updated
4 Oct 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing cognitive behavioral group therapy and Mindfulness-based group therapy in people with Fibromyalgia and PTSD, run by Bar-Ilan University, Israel at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Fibromyalgia Impact Questionnaire Revised (FIQR) (time frame: change through study completion, an average of 6 month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in